Comparative Analysis of the Clinical Features and Long-Term Outcomes of Pachychoroid Neovasculopathy and Type 1 Neovascular Age-Related Macular Degeneration

Figure 3

(a) Serial changes in the best-corrected visual acuity (BCVA) in the logMAR scale of individuals in the PCN and nAMD groups during the 5-year follow-up period. BCVA was significantly improved after 1 year in both the groups, and these improvements were maintained for 3 years after the initial treatment in PCN groups. However, BCVA improvements during the 5-year period did not significantly differ between the two groups. (b) Change in BCVA from baseline to 1, 3, and 5 years in terms of PCN and nAMD groups.

(a)

(b)